(78.6%). In urine samples, microorganisms were found resistant to cephradine in 95% cases but sensitive to cefixime in 30.4% cases. Microorganisms in blood samples were sensitive to cefixime in 83.3% and Ciprofloxacin in 80.6% cases. Ciprofloxacin, cephradin and cefixime all three antibiotics encountered resistance in 63.5%, 82.5% and 75.8% samples of pus respectively. Among sputum samples organisms were sensitive to ciprofloxacin in 71.4% and cefixime in 64.3% cases whereas resistant to cephradin in 92.9% cases. In organisms of throat swab Cephradine Showed sensitivity in 71.4% cases but cefixime encountered resistance in 57.1% cases.
Introduction
Antimicrobial resistance is a fluid and constantly evolving challenge of modern world. It has become a major obstacle to the treatment of infectious diseases worldwide. Antibiotic resistance has increased dramatically and rapidly during the 1990s, and it is widely acknowledged to be a serious threat to the treatment of infectious diseases on a global basis.
The morbidity, mortality and economic burden of infections with multiple drug resistant organisms, for which there are no effective therapies, pose an increasing burden for health care systems worldwide. The WHO report, entitled Overcoming Antimicrobial Resistance gives a stark warning that, at the dawn of a new millennium, humanity is faced with a crisis, where rising rates of drug resistance in many microorganisms could rob the world of its opportunity to cure many common infectious diseases. Overuse of antibiotics in developed nations and, paradoxically, both misuse and underuse in developing nations have contributed to the burden. Due to fears of resistance, many health care providers are avoiding narrow spectrum drugs in favour of broader spectrum antibiotics that have wider applications and greater impact on the natural flora. The report also indicated that unethical pharmaceutical companies sometimes pay a commission to physicians for recommending more expensive broader spectrum medications when cheaper narrow spectrum alternatives would suffice, resulting in a smaller, highly priced pool of antibiotics for a larger spectrum of infectious diseases 1,2 .
Antimicrobial agents are among the most frequently prescribed and inappropriate uses of these agents are associated with the development of antimicrobial resistance. Antibiotics are, frequently prescribed inappropriately in terms of type, dose, duration and indication. Despite the improved trend of health care in Bangladesh, infectious diseases remain priority public health problem, where widespread use of different antimicrobials against bacterial, fungal, viral and parasitic infections is required. Most antimicrobials are prescribed, with the decision to apply based on best-guess empiric therapy. A majority of the prescribers in Bangladesh diagnose infection by clinical assessment and suspect a microbial aetiology. Choosing an antimicrobial to which the infecting organism is susceptible means a shorter delay in starting effective treatment and a lower risk of poor outcomes and prolonged hospital stays, with their associated costs. 
Materials & Methods
This is an observational (retrospective) cross sectional type of study. The study was conducted at Armed Forces Institute of Pathology, Dhaka by reviewing the register which contains detail record of culture and sensitivity of different samples. All of the samples of urine (173), Blood (31), pus (63), sputum (28) and throat swab (14) tested for culture and sensitivity in that centre over a period from January 2012 to February 2013 were included in this study. Selected antibiotics were ciprofloxacin, cephradine and cefixime. Data were analyzed by using software IBM SPSS Statistics 19.0.
Result
In this study there are five different types of samples are considered. These are urine, blood, pus, sputum and throat swab. Total numbers of different samples were-Urine (173), Blood (31), Pus (63), Sputum (28) and Throat swab (14) . The study reveals the common organisms present in different samples and their sensitively to three selected antibiotics which are commonly used in practice. Diagram-1 shows the organisms isolated from urine, where E.coli is 100 (57.8%) most frequent, followed by Klebsiella 31 (17.9%) and Acinetobacter is 18 (10.4%). Among these Acinetobacter is highly capable of mutation thus develops resistance to antibiotics.
Diagram-1:
Organisms of urine.
Table-I shows the susceptibility of three selected antibiotics (Ciprofloxacin, Cephradine and Cefixime) to organisms of urine. Organisms were highly resistant to Cephradine (95%) and Cefixime (69.6%). But to ciprofloxacin which is widely used in cases of UTI in our country were found 72.8% resistant. Organisms from blood were highly sensitive to both cefixime and ciprofloxacin (Table-II) . Organisms were 83.3% and 80.6% sensitive to cefixime and ciprofloxacin respectively whereas they were mostly resistant to cephradine (65.4%). Organisms of sputum were highly resistant to both cephradine (92.9%) and ciprofloxacin (75.8%). But to cefixime they were moderately sensitive (64.3%) ( Table-IV) . Among the Organisms of throat swab streptococcus pyogens were highly frequent 11 (78.6%) out of total 14 samples which is illustrated in Diagram-5. Others are klebsiella (14.3%) and Staph aureus (7.1%).
Diagram-5:
Organisms isolated from throat swab.
Unlike other samples organisms were found moderately sensitive to cephradine (71.4%) in throat-swab isolates. On the other hand susceptibility of cefixime (42.9%) and ciprofloxacin (50%) were almost same ( Table-V) . 
Discussion
The study was conducted in Armed Forces Institute of Pathology to assess the current state of antimicrobial resistance of different samples mainly among the Armed Forces personnel. The aim of the study was to reveal the real picture of antimicrobial resistance in our country. Antibiotic resistance has increased dramatically and rapidly during 1990s and it is widely acknowledged to a serious threat to the treatment of infective diseases on a global basis. The spread of antibiotic resistance presents a major public health challenge for the future. There are clinical data and study are available in this particular field showing that treatment of bacterial infections with antibiotics to which the infecting pathogen is resistant is associated with morbidity, mortality and cost.
In this study five different types of samples were considered (Urine, blood, pus, sputum and throat swab) to identify common microorganisms and to assess their sensitivity to three selected antibiotics. In this study the organisms isolated from urine were E.coli 57. The study shows organisms isolated from sputum were Klebsiella 67.8%, Acinetobacter 14.3% and pseudomonas 10.7% which is almost same as another study conducted in 2012 at AFIP where pseudomonas was found 10%. Organisms of sputum were highly resistant to both cephradine (92.9%) and ciprofloxacin 75.8% but to cefixime they were found mostly sensitive (64.3%). A study in India shows Klebsiella were highly sensitive to quinolone (85%) but to cephalosporin (Ceftizoxime and cefotaxime) they were found 28% to 76% resistance. In another study from Gwalior, India reveals most of the klebsiella are multidrug resistance. A study in USA, 1998-2010 demonstrated significant increases in antimicrobial resistance of Klebsiella. The largest increases in antimicrobial drug resistance from 1998 to 2010 were observed for Aztreonam (7.7% to 22.2%), ceftazidime (5.5% to 17.2%), and ciprofloxacine (5.5% to 16.8%). There is three to four fold rise of antimicrobial resistance in USA over a decade which is even much lower than our country 13 .
In our study organisms isolated from throat swab were streptococcus pyogenes 78.6% followed by Klebsiella 14.3% and S. aureus 7.1%. A study in Benin reveals common organisms of throat swab were streptococcus pyogenes 48.72%, S. aureus 12.83% and Klebsiella 17.9% 14 , both studies reveal similar organisms on throat swab culture. In our study organisms of throat swab were found moderately sensitive to cephradine (71.4% It is clearly evident from our study that antimicrobial resistances to commonly used antibiotics were much higher than our expectation. Organisms were highly resistant (72.8%) to ciprofloxacin which is commonly used by our physician to treat UTI. In case of organisms of blood both ciprofloxacin (80.6%) and cefixime (83.3%) showed very good sensitivity. Organisms of pus were highly resistant to all the three antibiotics used in the study. On the other hand organisms of sputum were also found mostly resistant to antibiotics. Organisms isolated from throat swab showed better sensitivity to cephradine (71.4%) than cefixime (42.9%) and ciprofloxacin (50%).
The study showed the organisms of different samples were highly resistant to commonly used antibiotics even to third generation cephalosporins. Antibiotics become less effective against micro-organisms because of their indiscriminate, misuse, and over prescription by the physicians, non compliance of the patients, lack of awareness and lack of proper monitoring. Strict compliance of policy on drugs and continuous monitoring and surveillance may revert the current alarming situation of antimicrobial resistance in our country.
Conclusion
The study reveals a grave picture regarding the antimicrobial resistance in our country. The result may vary in the perspective of whole country as the study conducted at AFIP. Here most of the samples were collected from CMH, Dhaka which is the only referral hospital of Bangladesh Armed Forces and the cases were usually complicated.
There is no estimation about the actual cost of antimicrobial resistance in our country. But certainly it is a huge socio-economic burden for the countries like Bangladesh. According to the Centre for Disease Control and Prevention(CDC), antibiotic resistance in the United States costs an estimated $ 20 billion a year in excess health care costs, $ 35 million in other societal costs and more than $ 8 million additional days that people spend in the hospital(April 2011).
The irrational and inappropriate uses of antibiotics are the main culprit for the development of resistance of different species of microorganisms to antibiotics. There is an urgent need to develop and strengthen antimicrobial policy (which includes regulations of marketing, sales, use and consumption of these drugs), standard treatment guidelines and national plan for containment of antimicrobial resistance in Bangladesh. There should be more focus on surveillance and research related to public health aspects of antimicrobial resistance at community and hospital level. 
